Should Patients Be Required to Undergo Standard Chemotherapy Before Being Eligible for Novel Phase I Immunotherapy Clinical Trials?

Benjamin S. Wilfond, Christian Morales, Holly Taylor

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)66-67
Number of pages2
JournalAmerican Journal of Bioethics
Issue number4
StatePublished - Apr 3 2017

ASJC Scopus subject areas

  • Issues, ethics and legal aspects
  • Health Policy

Cite this